These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 32218231)

  • 1. Sacubitril/Valsartan Induces Global Cardiac Reverse Remodeling in Long-Lasting Heart Failure with Reduced Ejection Fraction: Standard and Advanced Echocardiographic Evidences.
    Castrichini M; Manca P; Nuzzi V; Barbati G; De Luca A; Korcova R; Stolfo D; Lenarda AD; Merlo M; Sinagra G
    J Clin Med; 2020 Mar; 9(4):. PubMed ID: 32218231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Left Atrial Functional Remodeling in Patients with Chronic Heart Failure Treated with Sacubitril/Valsartan.
    Correale M; Magnesa M; Mazzeo P; Fortunato M; Tricarico L; Leopizzi A; Mallardi A; Mennella R; Croella F; Iacoviello M; Di Biase M; Brunetti ND
    J Clin Med; 2023 Jan; 12(3):. PubMed ID: 36769734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reverse Remodeling Assessed by Left Atrial and Ventricular Strain Reflects Treatment Response to Sacubitril/Valsartan.
    Moon MG; Hwang IC; Lee HJ; Kim SH; Yoon YE; Park JB; Lee SP; Kim HK; Kim YJ; Cho GY
    JACC Cardiovasc Imaging; 2022 Sep; 15(9):1525-1541. PubMed ID: 36075612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deformation Imaging by Strain in Chronic Heart Failure Over Sacubitril-Valsartan: A Multicenter Echocardiographic Registry.
    Mandoli GE; Pastore MC; Giannoni A; Benfari G; Dini FL; Rosa G; Pugliese NR; Taddei C; Correale M; Brunetti ND; Mazzeo P; Carluccio E; Mengoni A; Guaricci AI; Piscitelli L; Citro R; Ciccarelli M; Novo G; Corrado E; Pasquini A; Loria V; De Carli G; Degiovanni A; Patti G; Santoro C; Moderato L; Cicoira M; Canepa M; Malagoli A; Emdin M; Cameli M
    ESC Heart Fail; 2023 Apr; 10(2):846-857. PubMed ID: 36448244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects and clinical implications of sacubitril/valsartan on left ventricular reverse remodeling in patients affected by chronic heart failure: A 24-month follow-up.
    Paolini C; Mugnai G; Dalla Valle C; Volpiana A; Ferraglia A; Frigo AC; Bilato C
    Int J Cardiol Heart Vasc; 2021 Aug; 35():100821. PubMed ID: 34179333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early improvement of strain imaging parameters predicts long-term response to sacubitril/valsartan in patients with heart failure with reduced ejection fraction: An observational prospective study.
    Camilli M; Iannaccone G; Russo M; Meucci MC; Chiorazzo G; Natali R; Mango F; Bonanni A; Montone RA; Graziani F; Locorotondo G; Massetti M; Lanza GA; Aspromonte N; Crea F; Lombardo A
    Int J Cardiol; 2023 Sep; 387():131110. PubMed ID: 37290664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ejection fraction improvement and reverse remodeling achieved with Sacubitril/Valsartan in heart failure with reduced ejection fraction patients.
    Almufleh A; Marbach J; Chih S; Stadnick E; Davies R; Liu P; Mielniczuk L
    Am J Cardiovasc Dis; 2017; 7(6):108-113. PubMed ID: 29348971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of sacubitril/valsartan effects on left ventricular dynamics using 3D echocardiography and 3D strain in heart failure with reduced ejection fraction patients.
    Öz TK; Abdelnabi M; Fiore C; Almaghraby A; Cihan D; Babazade N; Haseeb Raza Naqvi S; Omar B; Dağdeviren B
    Minerva Cardiol Angiol; 2022 Aug; 70(4):431-438. PubMed ID: 34713680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reverse remodelling by sacubitril/valsartan predicts the prognosis in heart failure with reduced ejection fraction.
    Moon MG; Hwang IC; Choi W; Cho GY; Yoon YE; Park JB; Lee SP; Kim HK; Kim YJ
    ESC Heart Fail; 2021 Jun; 8(3):2058-2069. PubMed ID: 33682334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of sacubitril/valsartan on echo parameters in heart failure patients with reduced ejection fraction a prospective evaluation.
    Bayard G; Da Costa A; Pierrard R; Roméyer-Bouchard C; Guichard JB; Isaaz K
    Int J Cardiol Heart Vasc; 2019 Dec; 25():100418. PubMed ID: 31517034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sacubitril/Valsartan Improves Left Ventricular Ejection Fraction and Reverses Cardiac Remodeling in Taiwanese Patients with Heart Failure and Reduced Ejection Fraction.
    Liu LW; Wu PC; Chiu MY; Tu PF; Fang CC
    Acta Cardiol Sin; 2020 Mar; 36(2):125-132. PubMed ID: 32201463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Change in N-Terminal Pro-B-Type Natriuretic Peptide Following Initiation of Sacubitril-Valsartan Treatment With Cardiac Structure and Function in Patients With Heart Failure With Reduced Ejection Fraction.
    Januzzi JL; Prescott MF; Butler J; Felker GM; Maisel AS; McCague K; Camacho A; Piña IL; Rocha RA; Shah AM; Williamson KM; Solomon SD;
    JAMA; 2019 Sep; 322(11):1085-1095. PubMed ID: 31475295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of sacubitril/valsartan in ESRD patients undergoing hemodialysis with HFpEF.
    Guo Y; Ren M; Wang T; Wang Y; Pu T; Li X; Yu L; Wang L; Liu P; Tang L
    Front Cardiovasc Med; 2022; 9():955780. PubMed ID: 36440034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Sacubitril-Valsartan vs Enalapril on Aortic Stiffness in Patients With Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.
    Desai AS; Solomon SD; Shah AM; Claggett BL; Fang JC; Izzo J; McCague K; Abbas CA; Rocha R; Mitchell GF;
    JAMA; 2019 Sep; 322(11):1077-1084. PubMed ID: 31475296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Sacubitril/Valsartan Treatment on Left Ventricular Myocardial Torsion Mechanics in Patients with Heart Failure Reduced Ejection Fraction 2D Speckle Tracking Echocardiography.
    Elshafey WEH; Al Khoufi EA; Elmelegy EK
    J Cardiovasc Echogr; 2021; 31(2):59-67. PubMed ID: 34485030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term echocardiographic evaluation by global longitudinal strain in patients with heart failure treated with sacubitril/valsartan.
    Mazzetti S; Scifo C; Abete R; Margonato D; Chioffi M; Rossi J; Pisani M; Passafaro G; Grillo M; Poggio D; Mortara A
    ESC Heart Fail; 2020 Jun; 7(3):964-972. PubMed ID: 32233080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sacubitril/valsartan reduces indications for arrhythmic primary prevention in heart failure with reduced ejection fraction: insights from DISCOVER-ARNI, a multicenter Italian register.
    Pastore MC; Mandoli GE; Giannoni A; Benfari G; Dini FL; Pugliese NR; Taddei C; Correale M; Brunetti ND; Carluccio E; Mengoni A; Guaricci AI; Piscitelli L; Citro R; Ciccarelli M; Novo G; Corrado E; Pasquini A; Loria V; Degiovanni A; Patti G; Santoro C; Moderato L; Malagoli A; Emdin M; Cameli M; ; Rosa G; Magnesa M; Mazzeo P; De Carli G; Bellino M; Iuliano G; Casciano O; Binno S; Canepa M; Tondi S; Cicoira M; Mega S
    Eur Heart J Open; 2022 Jan; 2(1):oeab046. PubMed ID: 35919657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term Effects of Sacubitril-Valsartan on Cardiac Remodeling: A Parallel Echocardiographic Study of Left and Right Heart Adaptive Response.
    Valli F; Bursi F; Santangelo G; Toriello F; Faggiano A; Rusconi I; Vella AM; Carugo S; Guazzi M
    J Clin Med; 2023 Apr; 12(7):. PubMed ID: 37048742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Long-Term Benefit of Sacubitril/Valsartan in Patients with HFrEF: A 5-Year Follow-Up Study in a Real World Population.
    Dattilo G; Laterra G; Licordari R; Parisi F; Pistelli L; Colarusso L; Zappia L; Vaccaro V; Demurtas E; Allegra M; Crea P; Di Bella G; Signorelli SS; Aspromonte N; Imbalzano E; Correale M
    J Clin Med; 2023 Sep; 12(19):. PubMed ID: 37834892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effects of Sacubitril/Valsartan on Clinical, Biochemical and Echocardiographic Parameters in Patients with Heart Failure with Reduced Ejection Fraction: The "Hemodynamic Recovery".
    Romano G; Vitale G; Ajello L; Agnese V; Bellavia D; Caccamo G; Corrado E; Di Gesaro G; Falletta C; La Franca E; Minà C; Storniolo SA; Sarullo FM; Clemenza F
    J Clin Med; 2019 Dec; 8(12):. PubMed ID: 31817815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.